← The Wire
MGNXNasdaq
MACROGENICS INC
Pharmaceutical Preparations · DE · CIK 1125345
Develops antibody-based cancer therapeutics, including ADCs and multi-specific antibodies
$252M
Market cap
$4.86
Last close
+1.0%
1D
+6.1%
5D
1.4M
Volume
Price · last 39 sessions+51.9%
May 4L $2.94 · H $4.86Jun 29
270
Total filings
May 20, 2026
Last filing
12/31
Fiscal year end
10-Q10-QMay 13, 202610-Q10-QNov 12, 202510-Q10-QAug 14, 202510-Q10-QMay 13, 202510-Q10-QNov 5, 202410-Q10-QAug 6, 202410-Q10-QMay 9, 202410-Q10-QNov 6, 202310-Q10-QAug 9, 202310-Q10-QMay 9, 202310-Q10-QNov 3, 202210-Q10-QAug 8, 202210-Q10-QMay 3, 202210-Q10-QNov 2, 202110-Q10-QJul 29, 202110-Q10-QApr 29, 202110-Q10-QNov 4, 202010-Q10-QJul 31, 202010-Q10-QMay 5, 202010-Q10-QNov 6, 201910-Q10-QJul 31, 201910-Q10-QMay 1, 201910-Q10-QNov 7, 201810-Q10-QAug 7, 201810-Q10-QMay 7, 201810-Q10-QNov 8, 201710-Q10-QAug 2, 201710-Q10-QMay 3, 201710-QFORM 10-QNov 2, 201610-QFORM 10-QAug 3, 201610-QFORM 10-QMay 4, 201610-QFORM 10-QNov 4, 201510-QFORM 10-QAug 5, 201510-QFORM 10-QMay 6, 201510-QFORM 10-QNov 12, 201410-Q10-QAug 5, 201410-QFORM 10-QMay 6, 201410-Q10-QNov 12, 2013
Similar companies
Comparable business profile · signals at a glance